Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Totzke

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Contemporary Clinical Trials|August 2, 2005
Non-frozen transports of whole blood samples do not cause relevant bias for global coagulation tests in clinical trials evaluating the drug safetyUwe Totzke, Cemal Kuyas
Oncology Research and Treatment|September 16, 2021
Effectiveness of Long-Term Treatment of Multiple Myeloma in Regular Care: Comparison of a Longitudinal and a Cross-Sectional Analysis ApproachTilman Steinmetz, Angela Ernst, Martin Hellmich, et al.
Clinical Chemistry and Laboratory Medicine|November 21, 2007
A new high-throughput screening method for the detection of chronic lymphatic leukemia and myelodysplastic syndromeElisabeth Haschke-Becher, Michael Vockenhuber, Paul Niedetzky, et al.
Annals of Hematology|August 22, 2024
MDS patient registries - achievements and challengesTilman Steinmetz, Uwe Totzke, Annika Kasprzak, et al.
International Journal of Technology Assessment in Health Care|April 1, 2009
Clinical decision rules for the use of liquor diagnostics in hospitalized neurology patients reduced costs without affecting clinical outcomesElisabeth Haschke-Becher, Uwe Totzke, Shahrzad Afazel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 24, 2026
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in GermanyTilman Steinmetz, Peter Jungberg, Dagmar Guth, et al.
The Oncologist|July 3, 2007
Prediction of the responsiveness to treatment with erythropoiesis-stimulating factors: a prospective clinical study in patients with solid tumorsTilman Steinmetz, Martin Hellmich, Michael Neise, et al.
Clinical Chemistry and Laboratory Medicine|June 5, 2013
Re-evaluation of laboratory predictors of response to current anemia treatment regimens of erythropoiesis stimulating agents in cancer patientsTilman Steinmetz, Kathrin Kuhr, Uwe Totzke, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Contemporary Clinical Trials|August 2, 2005
Non-frozen transports of whole blood samples do not cause relevant bias for global coagulation tests in clinical trials evaluating the drug safetyUwe Totzke, Cemal Kuyas
Oncology Research and Treatment|September 16, 2021
Effectiveness of Long-Term Treatment of Multiple Myeloma in Regular Care: Comparison of a Longitudinal and a Cross-Sectional Analysis ApproachTilman Steinmetz, Angela Ernst, Martin Hellmich, et al.
Clinical Chemistry and Laboratory Medicine|November 21, 2007
A new high-throughput screening method for the detection of chronic lymphatic leukemia and myelodysplastic syndromeElisabeth Haschke-Becher, Michael Vockenhuber, Paul Niedetzky, et al.
Annals of Hematology|August 22, 2024
MDS patient registries - achievements and challengesTilman Steinmetz, Uwe Totzke, Annika Kasprzak, et al.
International Journal of Technology Assessment in Health Care|April 1, 2009
Clinical decision rules for the use of liquor diagnostics in hospitalized neurology patients reduced costs without affecting clinical outcomesElisabeth Haschke-Becher, Uwe Totzke, Shahrzad Afazel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 24, 2026
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in GermanyTilman Steinmetz, Peter Jungberg, Dagmar Guth, et al.
The Oncologist|July 3, 2007
Prediction of the responsiveness to treatment with erythropoiesis-stimulating factors: a prospective clinical study in patients with solid tumorsTilman Steinmetz, Martin Hellmich, Michael Neise, et al.
Clinical Chemistry and Laboratory Medicine|June 5, 2013
Re-evaluation of laboratory predictors of response to current anemia treatment regimens of erythropoiesis stimulating agents in cancer patientsTilman Steinmetz, Kathrin Kuhr, Uwe Totzke, et al.
Pageof 1